More recently, another small-molecule MIF inhibitor, CPSI-1306, was shown to suppress tumor growth in triple-negative breast cancer models by inducing tumor cell apoptosis by downregulating survival and proliferation pathways [99]. This evidence concerns the gene MIF and triple-negative breast carcinoma.